Literature DB >> 26835512

HTLV-I Tax-Mediated Inactivation of Cell Cycle Checkpoints and DNA Repair Pathways Contribute to Cellular Transformation: "A Random Mutagenesis Model".

Christophe Nicot1.   

Abstract

To achieve cellular transformation, most oncogenic retroviruses use transduction by proto-oncogene capture or insertional mutagenesis, whereby provirus integration disrupts expression of tumor suppressors or proto-oncogenes. In contrast, the Human T-cell leukemia virus type 1 (HTLV-I) has been classified in a separate class referred to as "transactivating retroviruses". Current views suggest that the viral encoded Tax protein transactivates expression of cellular genes leading to deregulated growth and transformation. However, if Tax-mediated transactivation was indeed sufficient for cellular transformation, a fairly high frequency of infected cells would eventually become transformed. In contrast, the frequency of transformation by HTLV-I is very low, likely less than 5%. This review will discuss the current understanding and recent discoveries highlighting critical functions of Tax in cellular transformation. HTLV-I Tax carries out essential functions in order to override cell cycle checkpoints and deregulate cellular division. In addition, Tax expression is associated with increased DNA damage and genome instability. Since Tax can inhibit multiple DNA repair pathways and stimulate unfaithful DNA repair or bypass checkpoints, these processes allow accumulation of genetic mutations in the host genome. Given this, a "Random Mutagenesis" transformation model seems more suitable to characterize the oncogenic activities of HTLV-I.

Entities:  

Year:  2015        PMID: 26835512      PMCID: PMC4729388          DOI: 10.13188/2377-9292.1000009

Source DB:  PubMed          Journal:  J Cancer Sci        ISSN: 2377-9292


  91 in total

1.  Dose-dependent dual effect of HTLV-1 tax oncoprotein on p53-dependent nucleotide excision repair in human T-cells.

Authors:  Yana Schavinsky-Khrapunsky; Esther Priel; Mordechai Aboud
Journal:  Int J Cancer       Date:  2008-01-15       Impact factor: 7.396

Review 2.  An HTLV-I transgenic mouse model: role of the tax gene in pathogenesis in multiple organ systems.

Authors:  M I Nerenberg
Journal:  Curr Top Microbiol Immunol       Date:  1990       Impact factor: 4.291

3.  The DNA repair endonuclease XPG binds to proliferating cell nuclear antigen (PCNA) and shares sequence elements with the PCNA-binding regions of FEN-1 and cyclin-dependent kinase inhibitor p21.

Authors:  R Gary; D L Ludwig; H L Cornelius; M A MacInnes; M S Park
Journal:  J Biol Chem       Date:  1997-09-26       Impact factor: 5.157

4.  Exocrinopathy resembling Sjögren's syndrome in HTLV-1 tax transgenic mice.

Authors:  J E Green; S H Hinrichs; J Vogel; G Jay
Journal:  Nature       Date:  1989-09-07       Impact factor: 49.962

5.  Induction of reactive oxygen species by human T-cell leukemia virus type 1 tax correlates with DNA damage and expression of cellular senescence marker.

Authors:  Takao Kinjo; Julia Ham-Terhune; Jean-Marie Peloponese; Kuan-Teh Jeang
Journal:  J Virol       Date:  2010-03-10       Impact factor: 5.103

6.  Disruption of nucleotide excision repair by the human T-cell leukemia virus type 1 Tax protein.

Authors:  S Y Kao; S J Marriott
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

7.  Mutations of the p53 gene in adult T-cell leukemia.

Authors:  A Sakashita; T Hattori; C W Miller; H Suzushima; N Asou; K Takatsuki; H P Koeffler
Journal:  Blood       Date:  1992-01-15       Impact factor: 22.113

Review 8.  Transgenic mouse models for HTLV-I infection.

Authors:  W J Grossman; L Ratner
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1996

Review 9.  Cyclin-dependent kinases.

Authors:  Marcos Malumbres
Journal:  Genome Biol       Date:  2014       Impact factor: 13.583

10.  HTLV-1 Tax oncoprotein subverts the cellular DNA damage response via binding to DNA-dependent protein kinase.

Authors:  Sarah S Durkin; Xin Guo; Kimberly A Fryrear; Valia T Mihaylova; Saurabh K Gupta; S Mehdi Belgnaoui; Abdelali Haoudi; Gary M Kupfer; O John Semmes
Journal:  J Biol Chem       Date:  2008-10-27       Impact factor: 5.157

View more
  14 in total

1.  Stability of HTLV-2 antisense protein is controlled by PML nuclear bodies in a SUMO-dependent manner.

Authors:  Louise Dubuisson; Florence Lormières; Stefania Fochi; Jocelyn Turpin; Amandine Pasquier; Estelle Douceron; Anaïs Oliva; Ali Bazarbachi; Valérie Lallemand-Breitenbach; Hugues De Thé; Chloé Journo; Renaud Mahieux
Journal:  Oncogene       Date:  2018-03-06       Impact factor: 9.867

2.  Altered Expression of Cell Cycle Regulators in Adult T-Cell Leukemia/ Lymphoma Patients.

Authors:  Reza Torshizi; Ehsan Ghayour Karimani; Kobra Etminani; Mohammad Mehdi Akbarin; Khadijeh Jamialahmadi; Abbas Shirdel; Hossein Rahimi; Abolghasem Allahyari; Amin Golabpour; Houshang Rafatpanah
Journal:  Rep Biochem Mol Biol       Date:  2017-10

Review 3.  Adult T-cell leukemia: molecular basis for clonal expansion and transformation of HTLV-1-infected T cells.

Authors:  Toshiki Watanabe
Journal:  Blood       Date:  2017-01-23       Impact factor: 22.113

Review 4.  Molecular mechanisms of viral oncogenesis in humans.

Authors:  Nathan A Krump; Jianxin You
Journal:  Nat Rev Microbiol       Date:  2018-11       Impact factor: 60.633

5.  The Human T-Cell Leukemia Virus Type 1 Basic Leucine Zipper Factor Attenuates Repair of Double-Stranded DNA Breaks via Nonhomologous End Joining.

Authors:  Amanda W Rushing; Kimson Hoang; Nicholas Polakowski; Isabelle Lemasson
Journal:  J Virol       Date:  2018-07-17       Impact factor: 5.103

Review 6.  Viral Oncology: Molecular Biology and Pathogenesis.

Authors:  Uyen Ngoc Mui; Christopher T Haley; Stephen K Tyring
Journal:  J Clin Med       Date:  2017-11-29       Impact factor: 4.241

7.  Evaluation of the role of TAX, HBZ, and HTLV-1 proviral load on the survival of ATLL patients.

Authors:  Mohammad Mehdi Akbarin; Abbas Shirdel; Alireza Bari; Seyedeh Tahereh Mohaddes; Houshang Rafatpanah; Ehsan Ghayour Karimani; Kobra Etminani; Amin Golabpour; Reza Torshizi
Journal:  Blood Res       Date:  2017-06-22

8.  Undifferentiated Pleomorphic Sarcoma and the Importance of Considering the Oncogenic and Immune-Suppressant Role of the Human T-Cell Lymphotropic Virus Type 1: A Case Report.

Authors:  Sergio Lupo; Carolina Berini; Camila Cánepa; Eduardo Santini Araujo; Mirna Biglione
Journal:  Front Oncol       Date:  2017-05-24       Impact factor: 6.244

9.  JAG1 overexpression contributes to Notch1 signaling and the migration of HTLV-1-transformed ATL cells.

Authors:  Marcia Bellon; Ramona Moles; Hassiba Chaib-Mezrag; Joanna Pancewicz; Christophe Nicot
Journal:  J Hematol Oncol       Date:  2018-09-19       Impact factor: 17.388

10.  HTLV-1 as a Model for Virus and Host Coordinated Immunoediting.

Authors:  Talia M Mota; R Brad Jones
Journal:  Front Immunol       Date:  2019-09-24       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.